- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00588978
Impact of Diet and/or Exercise-induced Weight Loss on Cardiovascular Risk Factors
April 16, 2020 updated by: Yale University
Longitudinal Impact of Diet and/or Exercise-induced Weight Loss on Metabolic Markers of Cardiovascular Disease
The purpose of this pilot study is to examine the effect of diet and/or exercise-induced weight loss on nontraditional cardiovascular risk factors such as c-reactive protein, insulin levels and sex steroids in obese postmenopausal women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale Center for Clinical Investigation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- obese postmenopausal women
- able to exercise
- non-smokers
Exclusion Criteria:
- cardiovascular disease
- medications that would interfere with outcome measures (e.g., including ACE inhibitors, lipid lowering medications, beta-blockers, etc)
- known diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: 1
Diet alone
|
Three arms are included: Diet Alone, Exercise Alone, and Combined Diet and Exercise
|
|
ACTIVE_COMPARATOR: 2
Exercise alone
|
Three arms are included: Diet Alone, Exercise Alone, and Combined Diet and Exercise
|
|
ACTIVE_COMPARATOR: 3
Diet and exercise (combined)
|
Three arms are included: Diet Alone, Exercise Alone, and Combined Diet and Exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
c-reactive protein
Time Frame: baseline, every 1-2 weeks during intervention , then end-of-study
|
baseline, every 1-2 weeks during intervention , then end-of-study
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
HOMA (measure of insulin resistance) and sex steroids
Time Frame: baseline, every 1-2 weeks during intervention, then end-of-study
|
baseline, every 1-2 weeks during intervention, then end-of-study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Barbara I Gulanski, MD, MPH, Yale Univeristy School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 1, 2003
Primary Completion (ACTUAL)
February 1, 2007
Study Completion (ACTUAL)
December 1, 2008
Study Registration Dates
First Submitted
December 27, 2007
First Submitted That Met QC Criteria
January 8, 2008
First Posted (ESTIMATE)
January 9, 2008
Study Record Updates
Last Update Posted (ACTUAL)
April 17, 2020
Last Update Submitted That Met QC Criteria
April 16, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25094
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.